Orchestra BioMed Holdings, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $8.00K.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $26.00K, a 71.43% decline year-over-year.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $91.00K, a 405.56% increase year-over-year.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $171.00K, a 167.19% increase year-over-year.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $91.00K, a 62.08% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $240.00K, a 3.90% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $231.00K, a 90.91% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $121.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $8.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $26.00K 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $91.00K 10-K · filed 2026-03-12 | |
| 2025-03-31 | $91.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $240.00K 10-K · filed 2026-03-12 | |
| 2024-06-30 | $171.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $18.00K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $231.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $64.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $10.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $121.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $4.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $92.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $25.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |